Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Quest for the best.

Bruce Booth¹, Rodney Zemmel

¹McKinsey & Company's New York Office at 55 East 52nd Street 21st Floor, New York, New York, 10055, USA. Bruce_Booth@McKinsey.com

Nature Reviews. Drug Discovery

|October 4, 2003

Summary

Drug developers invest billions seeking blockbuster drugs. This analysis explores common differentiation themes in successful drugs to guide future high-revenue pharmaceutical innovation and investment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

US immigration order strikes against biotech.

Nature biotechnology·2017

Same author

Pharmaceutical R&D: the road to positive returns.

Nature reviews. Drug discovery·2009

Same author

Prospects for productivity.

Nature reviews. Drug discovery·2004

Same author

Oncology's trials.

Nature reviews. Drug discovery·2003

Same author

Value of novelty?

Nature reviews. Drug discovery·2002

Area of Science:

Pharmaceutical industry
Drug discovery and development
Market analysis

Background:

The pharmaceutical industry invests heavily in drug discovery, aiming for blockbuster drugs with multi-billion dollar revenue potential.
Significant financial resources are allocated annually to the high-risk pursuit of novel, commercially successful medications.
The economic viability of blockbuster drug development strategies warrants critical examination.

Purpose of the Study:

To analyze key themes of differentiation common among existing blockbuster drugs.
To examine the implications of these themes for the creation of future billion-dollar drugs.
To provide insights into optimizing investment in pharmaceutical research and development.

Main Methods:

Qualitative analysis of historical blockbuster drug case studies.
Identification and thematic analysis of common differentiation strategies.
Market performance data review for correlation with differentiation factors.

Main Results:

Blockbuster drugs often share distinct characteristics in their market positioning and therapeutic approach.
Successful differentiation strategies are crucial for achieving significant market share and revenue.
Investment in novel chemical entities alone does not guarantee blockbuster status.

Conclusions:

Understanding differentiation is paramount for successful drug development and maximizing return on investment.
Future pharmaceutical strategies should prioritize innovative differentiation alongside scientific advancement.
A focused approach on market differentiation can mitigate risks associated with high-cost drug development.

Related Experiment Videos